Renocrit 4000 IU Injection

About

Renocrit 4000 IU Injection is an erythropoiesis-stimulating agent (ESA) containing Epoetin alfa, a recombinant human erythropoietin. It functions by stimulating the bone marrow to produce more red blood cells, thereby increasing hemoglobin levels. This medication is primarily used to treat anemia associated with chronic kidney disease (CKD) in both dialysis and non-dialysis patients, as well as other conditions like chemotherapy-induced anemia. It helps to alleviate symptoms of anemia such as fatigue, shortness of breath, and reduced exercise capacity, significantly improving the patient's quality of life. The therapeutic goal is to maintain hemoglobin levels within a target range to avoid the risks associated with both anemia and excessively high hemoglobin, thereby reducing the need for blood transfusions.

Uses

• Treatment of anemia associated with chronic kidney disease.
• Management of chemotherapy-induced anemia in cancer patients.
• Reduction of allogeneic blood transfusions in surgery patients.
• Treatment of anemia in HIV-infected patients receiving zidovudine.

Directions For Use

Administered subcutaneously or intravenously by a healthcare professional. Dosage is individualized based on patient's hemoglobin levels and clinical response.

Benefits

• Increases red blood cell count and hemoglobin levels.
• Reduces symptoms of anemia like fatigue and weakness.
• Decreases the need for blood transfusions.
• Improves overall quality of life for anemic patients.
• Supports better oxygen delivery to tissues.
• Helps manage anemia in various chronic conditions.

Side Effects

• Hypertension
• Headache
• Arthralgia
• Fever
• Nausea
• Vomiting
• Rash
• Injection site pain
• Thrombosis
• Seizures
• Pure red cell aplasia
• Flu-like symptoms

Safety Measures

• Alcohol - No direct interaction, but excessive alcohol consumption can worsen anemia or liver function, potentially complicating treatment.
• Pregnancy - Use only if clearly needed and the potential benefits outweigh the risks to the fetus. Consult your doctor before use.
• Breastfeeding - It is unknown if Epoetin alfa is excreted into human breast milk. Caution should be exercised when administered to a nursing mother.
• Liver - Use with caution in patients with severe liver impairment, as liver conditions may alter the metabolism or clearance of the medication.
• Kidney - This medication is primarily indicated for anemia associated with chronic kidney disease. Dosage adjustments may be necessary in specific renal conditions not related to its primary indication.
• Lung - No specific contraindication, but monitor for any signs of pulmonary hypertension or worsening respiratory conditions during treatment.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.